![]() |
市場調査レポート
商品コード
1679219
イソ酪酸市場の2030年までの予測:タイプ、グレード、純度、エンドユーザー、地域別の世界分析Isobutyric Acid Market Forecasts to 2030 - Global Analysis By Type (Synthetic Isobutyric Acid and Renewable Isobutyric Acid), Grade (Industrial Grade and Reagent Grade), Purity, End User and By Geography |
||||||
カスタマイズ可能
|
イソ酪酸市場の2030年までの予測:タイプ、グレード、純度、エンドユーザー、地域別の世界分析 |
出版日: 2025年03月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界のイソ酪酸市場は2024年に1億9,826万米ドルを占め、2030年には3億2,706万米ドルに達すると予測され、予測期間中のCAGRは8.7%で成長する見込みです。
イソ酪酸は無色の揮発性カルボン酸で、化学式はC4H8O2です。刺激臭があり、天然では一部の食品やエッセンシャルオイルに含まれています。エステル、医薬品、香料の製造に使用され、様々な化学物質の合成の前駆体としても機能します。イソ酪酸は合成と再生可能の両方の形態で存在するため、様々な産業で重宝されています。
飼料添加物の需要拡大
動物飼料添加物への需要の高まりが、イソ酪酸市場の成長を大きく後押ししています。飼料添加物として、イソ酪酸は家畜飼料の栄養価と嗜好性を向上させ、消化と栄養吸収を高め、家畜の健康と成長を促進します。世界人口の増加と食肉製品の需要増加により、より効率的な畜産が行われるようになり、効果的な飼料添加物が必要とされています。この動向は、動物飼料分野におけるイソ酪酸の大きな市場機会を生み出しています。
原料価格の変動
原料価格、特にプロピレンと酪酸の価格変動は、イソ酪酸市場に大きな課題をもたらしています。これらの価格変動は予測不可能な生産コストにつながり、メーカーが一貫した価格戦略を維持する能力に影響を与えます。価格変動は利益率を低下させ、研究開発への投資を妨げ、最終的には市場の成長を制約し、企業の効果的な事業拡大と技術革新の能力を制限することになります。
肝疾患治療の可能性
イソ酪酸のような短鎖脂肪酸(SCFA)の肝疾患治療における新たな可能性は、大きな市場機会をもたらします。この用途は、従来の用途を超え、医薬品分野に新たな道を開くものです。イソ酪酸の医療用途における研究開発の進展は、ヘルスケアに対する意識の高まりや治療ソリューションへの投資と相まって、市場拡大の有望な展望を生み出しています。
環境規制の増加
厳しい環境規制がイソ酪酸市場に大きな脅威を与えています。イソ酪酸業界は、厳しい環境基準や持続可能性の要件に準拠する必要に迫られています。こうした規制は、よりクリーンな生産プロセスや環境保護対策への追加投資をしばしば必要とし、潜在的に操業コストを上昇させ、市場競争力に影響を与えます。
パンデミックはサプライチェーンと製造業務に混乱を引き起こし、イソ酪酸市場に影響を与えました。しかし、イソ酪酸は食品・飼料分野での用途が不可欠であるため、安定した需要を維持することができました。この危機は一時的な価格変動と物流の課題につながったが、同時に重要な化学製品の強固なサプライチェーンを維持することの重要性を浮き彫りにしました。
予測期間中、合成イソ酪酸セグメントが最大となる見込み
合成イソ酪酸セグメントは、費用対効果が高く、石油ベースの原料を容易に入手できることから市場を独占している4。この分野が突出しているのは、農業中間体、食品・香料、化学中間体、保護塗料、医薬化学品など、さまざまな産業で広く応用されているためです。同分野の成長は、確立された製造プロセスと信頼できるサプライチェーンによってさらに支えられています。
食品・香料分野は予測期間中に最も高いCAGRが見込まれる
予測期間中、天然香料や食品添加物の需要増加により、食品・香料分野が最も高い成長率を示すと予測されます。イソ酪酸は、心地よいアロマとフレーバーを作り出す重要な中間体としての役割を担っており、食品業界が革新的なオーガニックフレーバーに注力していることと相まって、同分野の成長を牽引しています。加工食品産業の拡大と、味覚体験の向上を求める消費者の嗜好の変化は、市場の拡大をさらに加速させる。
予測期間中、アジア太平洋地域は、特に中国とインドにおける大規模な化学製造施設と工業化の進展により、最大の市場シェアを占めると予想されます。同地域の優位性は、医薬品、香料、飼料添加物、化学中間体など様々な産業からの旺盛な需要に起因します。製造部門の拡大と最終用途での消費の増加は、アジア太平洋の市場ポジションをさらに強固なものにしています。
予測期間中、アジア太平洋地域は急速な工業化と経済発展に牽引され、最も高いCAGRを示すと予測されます。飲食品、化粧品、医薬品を含む様々な最終用途産業の人気の高まりが市場拡大を後押ししています。中間層の増加とイソ酪酸を使用した製品の消費向上が、この地域の目覚しい成長率に貢献しています。
According to Stratistics MRC, the Global Isobutyric Acid Market is accounted for $198.26 million in 2024 and is expected to reach $327.06 million by 2030 growing at a CAGR of 8.7% during the forecast period. Isobutyric acid is a colorless, volatile carboxylic acid with the chemical formula C4H8O2. It has a pungent odor and is naturally found in some foods and essential oils. Used in the production of esters, pharmaceuticals, and flavoring agents, it also serves as a precursor in the synthesis of various chemicals. Isobutyric acid exists in both synthetic and renewable forms, making it valuable in various industries.
Growing demand for animal feed additives
The increasing demand for animal feed additives is significantly driving the isobutyric acid market growth. As a feed additive, isobutyric acid improves the nutritional value and palatability of animal feed, enhancing digestion and nutrient absorption while promoting better livestock health and growth. The rising global population and increasing demand for meat products have led to more efficient animal husbandry practices, requiring effective feed additives. This trend has created substantial market opportunities for isobutyric acid in the animal feed sector.
Volatility in raw material prices
Fluctuations in raw material prices, particularly propylene and butyric acid, create significant challenges for the isobutyric acid market. These price variations lead to unpredictable production costs and affect manufacturers' ability to maintain consistent pricing strategies. The volatility results in reduced profit margins and hinders investment in research and development, ultimately constraining market growth and limiting companies' capacity to expand and innovate effectively.
Potential use in liver disease treatment
The emerging potential for Short-Chain Fatty Acids (SCFAs) like isobutyric acid in liver disease treatment presents a significant market opportunity. This application opens new avenues in the pharmaceutical sector, expanding beyond traditional uses. The growing research and development in medical applications of isobutyric acid, combined with increasing healthcare awareness and investment in therapeutic solutions, creates promising prospects for market expansion.
Increasing environmental regulations
Stringent environmental regulations pose a significant threat to the isobutyric acid market. The industry faces growing pressure to comply with strict environmental standards and sustainability requirements. These regulations often necessitate additional investments in cleaner production processes and environmental protection measures, potentially increasing operational costs and affecting market competitiveness.
The pandemic caused disruptions in supply chains and manufacturing operations, affecting the isobutyric acid market. However, the essential nature of its applications in food and animal feed sectors helped maintain steady demand. The crisis led to temporary price fluctuations and logistical challenges but also highlighted the importance of maintaining robust supply chains for critical chemical products.
The synthetic isobutyric acid segment is expected to be the largest during the forecast period
The synthetic isobutyric acid segment dominates the market due to its cost-effectiveness and easy accessibility of petroleum-based raw materials4. This segment's prominence is driven by its widespread application across various industries, including agricultural intermediates, food and flavors, chemical intermediates, protective coatings, and pharmaceutical chemicals. The segment's growth is further supported by established manufacturing processes and reliable supply chains.
The food & flavours segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the food & flavours segment is predicted to witness the highest growth rate due to increasing demand for natural flavoring agents and food additives. Isobutyric acid's role as a key intermediate in creating pleasant aromas and flavors, combined with the food industry's focus on innovative organic flavors, drives segment growth. The expanding processed food industry and changing consumer preferences for enhanced taste experiences further accelerate market expansion.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its extensive chemical manufacturing facilities and growing industrialization, particularly in China and India. The region's dominance is attributed to strong demand from various industries, including pharmaceuticals, flavors, animal feed additives, and chemical intermediates. The expanding manufacturing sector and increasing consumption in end-use applications further strengthen Asia Pacific's market position.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid industrialization and economic development. The increasing popularity of various end-use industries, including food and beverages, cosmetics, and pharmaceuticals, fuels market expansion. The growing middle class and improved consumption of products using isobutyric acids contribute to the region's impressive growth rate.
Key players in the market
Some of the key players in Isobutyric Acid Market include OQ Chemicals GmbH, Eastman Chemical Company, Tokyo Chemical Industry Co., Ltd., Snowco, Shanghai Aladdin Biochemical Technology Co., Ltd., Afyren, Lygos, Inc., Dow Inc., Jiangsu Dynamic Chemical Co., Ltd., Weifang Qiyi Chemical Co., Ltd., Yufeng International Group Co., Ltd., Nanjing Chemical Material Corp., FUJIFILM Wako Pure Chemical Corporation, Hubei Jusheng Technology Co., Ltd., Evonik, Glentham Life Sciences Limited, Central Drug House and AFYREN.
In May 2024, FUJIFILM Wako Pure Chemical Corporation announces today that operations began utilizing new equipment that will triple1 production capacity of GMP-compliant2 raw materials for pharmaceutical manufacturing at its Osaka facility, located at 6-1 Takata-cho, Amagasaki City, Hyogo Prefecture, Japan.
In March 2024, Evonik has signed a deal to sell its superabsorbents business to International Chemical Investors Group (ICIG), a privately-held industrial group headquartered in Germany. The transaction, in the low triple-digit million euro range, allows specialty-focussed Evonik to reduce its exposure to commodities, and is expected to close by mid-2024 following competition authority approval, according to the company. The business generated sales of €892 million in 2023, with adjusted earnings before interest, tax, depreciation and amortization (EBITDA) in the mid double-digit million euro range.
In March 2023, OQ Chemicals has launched "OxBalance Isononanoic Acid", the world's first commercially available isononanoic acid that is produced from both bio-based and circular feedstocks, and is ISCC PLUS certified. The new product has a bio-based content of over 70 percent, providing manufacturers with a sustainable and eco-friendly alternative to conventional isononanoic acid. To meet the growing demand for carboxylic acids, OQ Chemicals has recently invested in a capacity expansion project in Germany.